Cellular and immunologic mechanisms in atopic dermatitis

Journal of the American Academy of Dermatology

Volumn 44, Issue 1 SUPPL., 2001, Pages S1-

  Leung, Donald Y M ^a,b   Soter, Nicholas A ^c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; CYTOKINE; EMOLLIENT AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; SUPERANTIGEN; TACROLIMUS;

ARTICLE; ATOPIC DERMATITIS; AUTOREGULATION; CELL DIFFERENTIATION; CELL FUNCTION; CYTOKINE RELEASE; EFFECTOR CELL; EPIDERMIS; HELPER CELL; HEREDITY; HUMAN; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; MICROBIOLOGICAL EXAMINATION; PATHOGENESIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION;

EID: 0035153766     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.109815     Document Type: Article

References (100)

1. Diagnostic features of atopic dermatitis
2. Atopic dermatitis: New insights and opportunities for therapeutic intervention
3. The occurrence of atopic dermatitis in north Europe: An international questionnaire study
4. The prevalence of atopic dermatitis in Oregon schoolchildren
5. Differential cytokine profiles in peripheral blood supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis, and normal individuals
6. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis
7. Itch duration of the uninvolved skin of atopic dermatitis (prurigo Besnier)
8. Eczema in primary immune-deficiencies: Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome
9. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation
10. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis
11. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma
12. Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counterregulation by CLA- memory T cells
13. Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferongamma and neopterin in patients with severe atopic dermatitis
14. Decreased gamma interferon and increased interleukin-4 production promote IgE synthesis in atopic dermatitis
15. High frequency of IL-4 producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin
16. Skin-derived aeroallergen-specific T-cell clones of the Th2 phenotype in patients with atopic dermatitis
17. The structure of normal skin and the morphology of atopic eczema
18. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies
19. Dermal eosinophils in atopic dermatitis under cytolytic degeneration
20. Dermal deposition of eosinophil granule major basic protein in atopic dermatitis: Comparison with onchocerciasis
21. Enhanced expression of eotaxin and CCR3 in atopic dermatitis
22. Elevated RANTES levels in plasma or skin decreased plasma IL-10 levels in subsets of patients with severe atopic dermatitis
23. Correlation of eosinophils, eosinophil cationic protein, soluble interleukin-2 receptor with the clinical activity of atopic dermatitis
24. E-selectin and vascular cell adhesion molecule-1 as critical adhesion molecules for infiltration of T lymphocytes and eosinophils in atopic dermatitis
25. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis
26. In vivo expression of IL-12 and IL-13 in atopic dermatitis
27. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis
28. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis
29. In vivo expression of cytokine receptor mRNA in atopic dermatitis
30. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
31. IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures
32. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum IgE concentrations
33. Identifying gene predisposing to atopic eczerna
34. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy
35. Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element
36. Linkage and association of an interlieukin 4 gene polymorphism with atopic dermatitis in Japanese families
37. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
38. Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from children with atopic dermatitis
39. Type 4 phosphodiesterase J inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis
40. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes
41. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis
42. Overexpression of IL-10 in atopic dermatitis: Contrasting cytokine patterns with delayed-type hypersensitivity reactions
43. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
44. Enhanced expression of B7.2 (CD86) in patients with dermatitis: A potential role in the modulation of atopic IgE synthesis
45. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma
46. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells
47. Messenger RNA expression of cytokine gene cluster, interleukin 3 (IL-3), IL-5, and granulocyte/macrophage colony-stimulating factor in allergen-induced late-phase cutaneous reactions in a topic subjects
48. Interleukin-1 is released at sites of human cutaneous allergic reactions
49. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: Association with expression of VCAM-1
50. Expression Of an endothelial leukocyte adhesion molecule (ELAM-1) in elicited late phase allergic skin reactions
51. The presence of IgE on monocytes/macrophages infiltrating into the skin lesion of atopic dermatitis
52. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions
53. The high-affinity receptor for IgE is the predominant IgE-binding structure in lesional skin of atopic dermatitis patients
54. 2/CD23 on normal human monocytes
55. Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes
56. Circulating IgG antibodies to IgE in atopic syndromes
57. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE
58. Immunoglobulin E response to human proteins in atopic patients
59. Eczema and environment
60. Inflammatory skin diseases, T cells, and immune surveillance
61. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin
62. Lymphocyte homing and homeostasis
63. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites
64. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen
65. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen
66. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen (CLA)
67. A clinical, mycological and immunological survey for dermatophytosis
68. Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis
69. Contact sensitivity to Pityrosporum ovale in patients with atopic dermatitis
70. Selective cloning of allergens from the skin colonizing yeast Malassezia furfur by phage surface display technology
71. Ketoconazole in atopic dermatitis: Therapeutic response is correlated with decrease in serum IgE
72. Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis
73. Staphylococcus aureus in the lesions of atopic dermatitis
74. Staphylococcus aureus skin colonization in atopic dermatitis patients
75. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy
76. Evidence for a disease-promoting effect of staphylococcus aureus-derived exotoxins in atopic dermatitis
77. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis
78. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis
79. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production
80. Induction of corticosteroid insensitivity in human peripheral blood mononuclear cells by microbial superantigens
81. Application of staphylococcal enterotoxin B on normal and atopic skin induces upregulation of T cells via a superantigen-mediated mechanism
82. Atopic dermatitis and staphylococcal superantigens
83. Evidence for superantigen involvement in skin homing T cells in atopic dermatitis
84. Proliferation and production of interferon-gamma (IFN-gamma) and IL-4 in response to Staphylococcus aureus and staphylococcal superantigen in childhood atopic dermatitis
85. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergens
86. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes
87. Decreased levels of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin?
88. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis
89. Two ceramide subfractions detectable in CER(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema
90. Abnormal expression sphingomyelin acylase in atopic dermatitis: An etiologic factor for ceramide deficiency?
91. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis
92. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels
93. Recombinant interferon gamma therapy for atopic dermatitis
94. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis
95. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells
96. Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody
97. New concepts in atopic dermatitis
98. The immunosuppressant FKS06 selectively inhibits expression of early T cell activation genes
99. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children
100. Tacrolimus ointment for atopic dermatitis